Demo data. These are fictitious sample companies used to preview GroWiser. The figures are not real and are not investment information.
Himgiri Pharma Ltd
NSE: HIMGIRIPHBSE: 514760Pharma Formulations
₹2,019.55
▲ 30.30 (+1.52%)
Balance Sheet
- FY22: 3,345
- FY23: 3,734
- FY24: 4,160
- FY25: 4,583
- FY26: 5,105
- FY22: 665
- FY23: 824
- FY24: 1,159
- FY25: 921
- FY26: 719
- FY22: 4,750
- FY23: 5,305
- FY24: 5,997
- FY25: 6,311
- FY26: 6,878
| ₹ Cr | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Share capital | 22 | 22 | 22 | 22 | 22 |
| Reserves | 3,323 | 3,712 | 4,138 | 4,561 | 5,084 |
| Total equity | 3,345 | 3,734 | 4,160 | 4,583 | 5,105 |
| Borrowings | 665 | 824 | 1,159 | 921 | 719 |
| Trade payables | 458 | 406 | 388 | 426 | 489 |
| Other current liabilities | 247 | 304 | 250 | 336 | 406 |
| Other liabilities | 35 | 36 | 40 | 45 | 158 |
| Total liabilities | 4,750 | 5,305 | 5,997 | 6,311 | 6,878 |
| Net block | 2,321 | 2,558 | 2,736 | 3,090 | 3,317 |
| Capital work in progress | 94 | 155 | 192 | 148 | 236 |
| Investments | 438 | 782 | 930 | 636 | 571 |
| Inventories | 751 | 636 | 604 | 909 | 978 |
| Trade receivables | 528 | 560 | 653 | 958 | 744 |
| Cash & equivalents | 479 | 363 | 626 | 305 | 425 |
| Other current assets | 139 | 250 | 255 | 264 | 607 |
| Total assets | 4,750 | 5,305 | 5,997 | 6,311 | 6,878 |
Figures in ₹ Cr unless marked per share (₹). Consolidated.
Showing 5 of 10 periods. Premium unlocks the full 10-year history. See Premium